New AIM placing for EpiStem to aid with development of Genedrive diagnostic
EpiStem, a biotechnology and personalised medicine company, has used its Alternative Investment Market listing to raise £4.3 million.
News
EpiStem, a biotechnology and personalised medicine company, has used its Alternative Investment Market listing to raise £4.3 million.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software